Current treatment practices and prognostic factors in early-stage ovarian cancer - an analysis of the NOGGO/JAGO

Background: Surgery is the backbone of early-stage ovarian cancer (OC) management. However, in practice, there is disagreement about the extent of surgical staging and whether additional adjuvant treatment should be provided. As omitting relevant diagnostic or therapeutic procedures might lead to un...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Heublein, Sabine (VerfasserIn) , Baum, Joanna (VerfasserIn) , Jaeger, Anna (VerfasserIn) , Grimm-Glang, Donata (VerfasserIn) , Olthoff, Julia (VerfasserIn) , Braicu, Elena Ioana (VerfasserIn) , Azzam Nieto, Osama (VerfasserIn) , Haßdenteufel, Kathrin (VerfasserIn) , Schmalfeldt, Barbara (VerfasserIn) , Hanker, Lars (VerfasserIn) , Wallwiener, Markus (VerfasserIn) , Schneeweiss, Andreas (VerfasserIn) , Sehouli, Jalid (VerfasserIn) , Pietzner, Klaus (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 29 March 2023
In: Cancers
Year: 2023, Jahrgang: 15, Heft: 7, Pages: 1-15
ISSN:2072-6694
DOI:10.3390/cancers15072038
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/cancers15072038
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2072-6694/15/7/2038
Volltext
Verfasserangaben:Sabine Heublein, Joanna Baum, Anna Jaeger, Donata Grimm-Glang, Julia Olthoff, Elena Ioana Braicu, Osama Azzam Nieto, Kathrin Hassdenteufel, Barbara Schmalfeldt, Lars Hanker, Markus Wallwiener, Andreas Schneeweiss, Jalid Sehouli and Klaus Pietzner

MARC

LEADER 00000caa a2200000 c 4500
001 1845962451
003 DE-627
005 20230706205712.0
007 cr uuu---uuuuu
008 230523s2023 xx |||||o 00| ||eng c
024 7 |a 10.3390/cancers15072038  |2 doi 
035 |a (DE-627)1845962451 
035 |a (DE-599)KXP1845962451 
035 |a (OCoLC)1389530038 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Heublein, Sabine  |e VerfasserIn  |0 (DE-588)1109920091  |0 (DE-627)864502745  |0 (DE-576)475662733  |4 aut 
245 1 0 |a Current treatment practices and prognostic factors in early-stage ovarian cancer - an analysis of the NOGGO/JAGO  |c Sabine Heublein, Joanna Baum, Anna Jaeger, Donata Grimm-Glang, Julia Olthoff, Elena Ioana Braicu, Osama Azzam Nieto, Kathrin Hassdenteufel, Barbara Schmalfeldt, Lars Hanker, Markus Wallwiener, Andreas Schneeweiss, Jalid Sehouli and Klaus Pietzner 
264 1 |c 29 March 2023 
300 |a 15 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 23.05.2023 
520 |a Background: Surgery is the backbone of early-stage ovarian cancer (OC) management. However, in practice, there is disagreement about the extent of surgical staging and whether additional adjuvant treatment should be provided. As omitting relevant diagnostic or therapeutic procedures might lead to undertreatment, we aimed to structurally investigate treatment practice in addition to prognostic factors in a multicentre series of patients (pts) diagnosed with early-stage OC. Patients: Within this retrospective, multicentre study, medical records of 379 pts who had undergone surgery for suspected early-stage OC between January 2014 and March 2020 were analysed. Results: Of the 379 patients, 292 had pT stage 1a-2a and had complete data on the extent of surgical staging. At least one surgical step was omitted in 100 pts (34.2%). Complete surgical staging (n = 192; (65.8%)) was more often performed in high-grade serous OC and was independent of the healthcare level of the hospital where the initial diagnosis was made. Missing to take peritoneal biopsies was associated with reduced relapse-free-survival in incompletely staged, pT1 cases (p = 0.03). About every second patient (46.7%) with a final stage lower than FIGO IIB and treated with adjuvant chemotherapy received combination chemotherapy. BRCA1 and BRCA2 testing was only performed in a subset of pts, and mutations were detected in 18% (14/79) and 9% (7/85) pts, respectively. Conclusions: This study helps to increase our understanding of early-stage OC treatment and prognosis. In addition to treating patients in compliance with current guidelines, the need for BRCA testing should also be considered for early-stage OC. 
650 4 |a adjuvant treatment 
650 4 |a BRCA 
650 4 |a early-stage ovarian cancer 
650 4 |a surgery 
700 1 |a Baum, Joanna  |e VerfasserIn  |4 aut 
700 1 |a Jaeger, Anna  |e VerfasserIn  |4 aut 
700 1 |a Grimm-Glang, Donata  |e VerfasserIn  |4 aut 
700 1 |a Olthoff, Julia  |e VerfasserIn  |4 aut 
700 1 |a Braicu, Elena Ioana  |e VerfasserIn  |4 aut 
700 1 |a Azzam Nieto, Osama  |e VerfasserIn  |0 (DE-588)1266036830  |0 (DE-627)181492583X  |4 aut 
700 1 |a Haßdenteufel, Kathrin  |d 1994-  |e VerfasserIn  |0 (DE-588)1231317884  |0 (DE-627)1753999324  |4 aut 
700 1 |a Schmalfeldt, Barbara  |e VerfasserIn  |4 aut 
700 1 |a Hanker, Lars  |e VerfasserIn  |4 aut 
700 1 |a Wallwiener, Markus  |d 1980-  |e VerfasserIn  |0 (DE-588)134044827  |0 (DE-627)692043934  |0 (DE-576)27468327X  |4 aut 
700 1 |a Schneeweiss, Andreas  |d 1961-  |e VerfasserIn  |0 (DE-588)109972554  |0 (DE-627)632849630  |0 (DE-576)327251859  |4 aut 
700 1 |a Sehouli, Jalid  |e VerfasserIn  |4 aut 
700 1 |a Pietzner, Klaus  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Cancers  |d Basel : MDPI, 2009  |g 15(2023), 7 vom: März, Artikel-ID 2038, Seite 1-15  |h Online-Ressource  |w (DE-627)614095670  |w (DE-600)2527080-1  |w (DE-576)313958548  |x 2072-6694  |7 nnas  |a Current treatment practices and prognostic factors in early-stage ovarian cancer - an analysis of the NOGGO/JAGO 
773 1 8 |g volume:15  |g year:2023  |g number:7  |g month:03  |g elocationid:2038  |g pages:1-15  |g extent:15  |a Current treatment practices and prognostic factors in early-stage ovarian cancer - an analysis of the NOGGO/JAGO 
856 4 0 |u https://doi.org/10.3390/cancers15072038  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.mdpi.com/2072-6694/15/7/2038  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230523 
993 |a Article 
994 |a 2023 
998 |g 109972554  |a Schneeweiss, Andreas  |m 109972554:Schneeweiss, Andreas  |d 910000  |d 910400  |d 50000  |e 910000PS109972554  |e 910400PS109972554  |e 50000PS109972554  |k 0/910000/  |k 1/910000/910400/  |k 0/50000/  |p 12 
998 |g 134044827  |a Wallwiener, Markus  |m 134044827:Wallwiener, Markus  |d 910000  |d 910400  |d 50000  |e 910000PW134044827  |e 910400PW134044827  |e 50000PW134044827  |k 0/910000/  |k 1/910000/910400/  |k 0/50000/  |p 11 
998 |g 1231317884  |a Haßdenteufel, Kathrin  |m 1231317884:Haßdenteufel, Kathrin  |d 910000  |d 910400  |e 910000PH1231317884  |e 910400PH1231317884  |k 0/910000/  |k 1/910000/910400/  |p 8 
998 |g 1266036830  |a Azzam Nieto, Osama  |m 1266036830:Azzam Nieto, Osama  |d 910000  |d 910400  |e 910000PA1266036830  |e 910400PA1266036830  |k 0/910000/  |k 1/910000/910400/  |p 7 
998 |g 1109920091  |a Heublein, Sabine  |m 1109920091:Heublein, Sabine  |d 910000  |d 910400  |d 50000  |e 910000PH1109920091  |e 910400PH1109920091  |e 50000PH1109920091  |k 0/910000/  |k 1/910000/910400/  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1845962451  |e 4324598894 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedDisp":"29 March 2023","dateIssuedKey":"2023"}],"relHost":[{"title":[{"title_sort":"Cancers","title":"Cancers"}],"id":{"eki":["614095670"],"issn":["2072-6694"],"zdb":["2527080-1"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"2009-","publisher":"MDPI","publisherPlace":"Basel","dateIssuedKey":"2009"}],"name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]},"recId":"614095670","disp":"Current treatment practices and prognostic factors in early-stage ovarian cancer - an analysis of the NOGGO/JAGOCancers","type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"part":{"text":"15(2023), 7 vom: März, Artikel-ID 2038, Seite 1-15","extent":"15","pages":"1-15","issue":"7","volume":"15","year":"2023"},"pubHistory":["1.2009 -"],"note":["Gesehen am 27.05.2020"]}],"physDesc":[{"extent":"15 S."}],"id":{"doi":["10.3390/cancers15072038"],"eki":["1845962451"]},"title":[{"title":"Current treatment practices and prognostic factors in early-stage ovarian cancer - an analysis of the NOGGO/JAGO","title_sort":"Current treatment practices and prognostic factors in early-stage ovarian cancer - an analysis of the NOGGO/JAGO"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 23.05.2023"],"recId":"1845962451","person":[{"family":"Heublein","role":"aut","given":"Sabine","display":"Heublein, Sabine"},{"family":"Baum","role":"aut","given":"Joanna","display":"Baum, Joanna"},{"role":"aut","family":"Jaeger","display":"Jaeger, Anna","given":"Anna"},{"given":"Donata","display":"Grimm-Glang, Donata","role":"aut","family":"Grimm-Glang"},{"role":"aut","family":"Olthoff","given":"Julia","display":"Olthoff, Julia"},{"role":"aut","family":"Braicu","given":"Elena Ioana","display":"Braicu, Elena Ioana"},{"family":"Azzam Nieto","role":"aut","display":"Azzam Nieto, Osama","given":"Osama"},{"given":"Kathrin","display":"Haßdenteufel, Kathrin","role":"aut","family":"Haßdenteufel"},{"given":"Barbara","display":"Schmalfeldt, Barbara","family":"Schmalfeldt","role":"aut"},{"display":"Hanker, Lars","given":"Lars","family":"Hanker","role":"aut"},{"given":"Markus","display":"Wallwiener, Markus","family":"Wallwiener","role":"aut"},{"family":"Schneeweiss","role":"aut","given":"Andreas","display":"Schneeweiss, Andreas"},{"role":"aut","family":"Sehouli","display":"Sehouli, Jalid","given":"Jalid"},{"role":"aut","family":"Pietzner","display":"Pietzner, Klaus","given":"Klaus"}],"language":["eng"],"name":{"displayForm":["Sabine Heublein, Joanna Baum, Anna Jaeger, Donata Grimm-Glang, Julia Olthoff, Elena Ioana Braicu, Osama Azzam Nieto, Kathrin Hassdenteufel, Barbara Schmalfeldt, Lars Hanker, Markus Wallwiener, Andreas Schneeweiss, Jalid Sehouli and Klaus Pietzner"]}} 
SRT |a HEUBLEINSACURRENTTRE2920